Literature DB >> 26018113

Monitoring the menstrual cycle: Comparison of urinary and serum reproductive hormones referenced to true ovulation.

Judith Roos1, Sarah Johnson2, Sarah Weddell2, Erhard Godehardt3, Julia Schiffner4, Günter Freundl1, Christian Gnoth1.   

Abstract

OBJECTIVE: The aim of the study was to examine relationships and interindividual variations in urinary and serum reproductive hormone levels relative to ultrasound-observed ovulation in menstrual cycles of apparently normally menstruating women.
METHODS: This was a prospective study of normally menstruating women (no known subfertility), aged 18-40 years (n = 40), who collected daily urine samples and attended the study centre for blood samples and transvaginal ultrasound during one complete menstrual cycle. Serum luteinising hormone (LH), progesterone, estradiol, urinary LH, pregnanediol-3- glucuronide (P3G) and estrone-3-glucuronide were measured. Ultrasound was conducted by two physicians and interpreted by central expert review.
RESULTS: Menstrual cycle length varied from 22 to 37 days (median 27 days). Ovulation by ultrasound ranged from day 8 to day 26 (median day 15). Serum and urinary hormone profiles showed excellent agreement. Estrogen and LH hormone peaks in urine and serum showed a range of signal characteristics across the study group before and after ovulation. The rise in estrogen and LH always occurred before ovulation; the progesterone rise from baseline always occurred after ovulation.
CONCLUSIONS: Urinary and serum reproductive hormones showed excellent agreement and may be used interchangeably. The beginning of the surge in serum and urinary LH was an excellent predictor of ovulation. The rise in progesterone and P3G above baseline was a consistent marker of luteinisation confirming ovulation. Both LH and progesterone surges delivered clear, sharp signals in all volunteers, allowing reliable detection and confirmation of ovulation.

Entities:  

Keywords:  Estradiol; Estrone-3-glucuronide (E3G); Luteinising hormone (LH); Ovulation; Pregnanediol-3-glucuronide (P3G); Progesterone; Reproductive hormones; Transvaginal ultrasound

Mesh:

Substances:

Year:  2015        PMID: 26018113     DOI: 10.3109/13625187.2015.1048331

Source DB:  PubMed          Journal:  Eur J Contracept Reprod Health Care        ISSN: 1362-5187            Impact factor:   1.848


  20 in total

1.  Nausea and vomiting in pregnancy is not just 'morning sickness': data from a prospective cohort study in the UK.

Authors:  Roger Gadsby; Diana Ivanova; Emma Trevelyan; Jane L Hutton; Sarah Johnson
Journal:  Br J Gen Pract       Date:  2020-07-30       Impact factor: 5.386

2.  Concordance of self-reported hormonal contraceptive use and presence of exogenous hormones in serum among African women.

Authors:  Maria Pyra; Jairam R Lingappa; Renee Heffron; David W Erikson; Steven W Blue; Rena C Patel; Kavita Nanda; Helen Rees; Nelly R Mugo; Nicole L Davis; Athena P Kourtis; Jared M Baeten
Journal:  Contraception       Date:  2018-02-17       Impact factor: 3.375

3.  Impact of hypocaloric dietary intervention on ovulation in obese women with PCOS.

Authors:  Brittany Y Jarrett; Marla E Lujan
Journal:  Reproduction       Date:  2016-10-31       Impact factor: 3.906

4.  Real-life insights on menstrual cycles and ovulation using big data.

Authors:  I Soumpasis; B Grace; S Johnson
Journal:  Hum Reprod Open       Date:  2020-04-16

5.  Confirmation of ovulation from urinary progesterone analysis: assessment of two automated assay platforms.

Authors:  Robert M Gifford; Forbes Howie; Kirsten Wilson; Neil Johnston; Tommaso Todisco; Mike Crane; Julie P Greeves; Karolina Skorupskaite; David R Woods; Rebecca M Reynolds; Richard A Anderson
Journal:  Sci Rep       Date:  2018-12-04       Impact factor: 4.379

6.  Pilot observational prospective cohort study on the use of a novel home-based urinary pregnanediol 3-glucuronide (PDG) test to confirm ovulation when used as adjunct to fertility awareness methods (FAMs) stage 1.

Authors:  Rene Leiva; Marie McNamara-Kilian; Helen Niezgoda; René Ecochard; Thomas Bouchard
Journal:  BMJ Open       Date:  2019-05-27       Impact factor: 2.692

7.  Plasma volume variation across the menstrual cycle among healthy women of reproductive age: A prospective cohort study.

Authors:  Sixtus Aguree; Hilary J Bethancourt; Leigh A Taylor; Asher Y Rosinger; Alison D Gernand
Journal:  Physiol Rep       Date:  2020-04

8.  Towards the Clinical Evaluation of the Luteal Phase in Fertile Women: A Preliminary Study of Normative Urinary Hormone Profiles.

Authors:  María Elena Alliende; José Antonio Arraztoa; Ulises Guajardo; Fernando Mellado
Journal:  Front Public Health       Date:  2018-05-31

Review 9.  The Use of Estrone-3-Glucuronide and Pregnanediol-3-Glucuronide Excretion Rates to Navigate the Continuum of Ovarian Activity.

Authors:  Leonard F Blackwell; Delwyn G Cooke; Simon Brown
Journal:  Front Public Health       Date:  2018-05-31

10.  Evaluating urinary estrogen and progesterone metabolites using dried filter paper samples and gas chromatography with tandem mass spectrometry (GC-MS/MS).

Authors:  Mark Newman; Suzanne M Pratt; Desmond A Curran; Frank Z Stanczyk
Journal:  BMC Chem       Date:  2019-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.